Fuchs endothelial corneal dystrophy: current perspectives
Gustavo Vedana, Guadalupe Villarreal Jr, Albert S Jun Wilmer Eye Institute, Johns Hopkins Medical Institutions, Baltimore, MD, USA Abstract: Fuchs endothelial corneal dystrophy (FECD) is the most common corneal dystrophy and frequently results in ...
Jun AS, Villarreal Jr G, Vedana G
core
Pharmacological and Molecular Characterisation of P2Y Receptors in Endothelial and Epithelial Cells [PDF]
Submitted in partial fulfilment of the requirements of the University of Wolverhampton for the degree of Doctor of PhilosophyIn light of the significant modulation of receptor activity previously shown by a peptide (designated L247), designed to mimic ...
D’Souza, Vijay Kenneth
core
A synergistic antioxidant nanozyme platform for corneal neovascularization treatment. [PDF]
Su M +6 more
europepmc +1 more source
Diagnostic and therapeutic potential of carbon nanodots for ocular disease. [PDF]
Mohapatra D, Corson TW.
europepmc +1 more source
Specialized Pro-Resolving Mediators at the Ocular Surface: Biosynthesis, Mechanisms, and Therapeutic Potential. [PDF]
Gandhi S, Shokravi A, Buhrow S, Balas M.
europepmc +1 more source
Bioprinting the Craniofacial Region: A New Era in Regenerative Medicine and Dentistry. [PDF]
Abuarqoub D +4 more
europepmc +1 more source
NAMPT Deficiency Promotes Endothelial-Mesenchymal Transition by Inhibiting Energy Metabolism and Lysosomal Acidification in Late-Onset Fuchs Endothelial Corneal Dystrophy. [PDF]
Xie L +10 more
europepmc +1 more source
Role of stem cells in ocular diseases: Progress and challenges. [PDF]
Fu T +5 more
europepmc +1 more source
A bioactivity-enhanced thermosensitive amnion-derived hydrogel with sustained IGF-1 release: A multitargeted and efficient strategy for corneal injury repair. [PDF]
Xie M +11 more
europepmc +1 more source
TCF4 trinucleotide repeat expansion drives distinct proteomic signatures in Fuchs endothelial corneal dystrophy. [PDF]
Yuasa T +17 more
europepmc +1 more source

